King Jasmine L, Shrivastava Roopali, Shah Pooja D, Maturavongsadit Panita, Benhabbour Soumya Rahima
Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Joint Department of Biomedical Engineering, North Carolina State University and The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Pharmaceutics. 2023 Sep 2;15(9):2270. doi: 10.3390/pharmaceutics15092270.
Bone fractures are common in the geriatric population and pose a great economic burden worldwide. While traditional methods for repairing bone defects have primarily been autografts, there are several drawbacks limiting its use. Bone graft substitutes have been used as alternative strategies to improve bone healing. However, there remain several impediments to achieving the desired healing outcomes. Injectable hydrogels have become attractive scaffold materials for bone regeneration, given their high performance in filling irregularly sized bone defects and their ability to encapsulate cells and bioactive molecules and mimic the native ECM of bone. We investigated the use of an injectable chitosan-based hydrogel scaffold to promote the differentiation of preosteoblasts in vitro. The hydrogels were characterized by evaluating cell homogeneity, cell viability, rheological and mechanical properties, and differentiation ability of preosteoblasts in hydrogel scaffolds. Cell-laden hydrogel scaffolds exhibited shear thinning behavior and the ability to maintain shape fidelity after injection. The CNC-CS hydrogels exhibited higher mechanical strength and significantly upregulated the osteogenic activity and differentiation of preosteoblasts, as shown by ALP activity assays and histological analysis of hydrogel scaffolds. These results suggest that this injectable hydrogel is suitable for cell survival, can promote osteogenic differentiation of preosteoblasts, and structurally support new bone growth.
骨折在老年人群中很常见,在全球范围内造成了巨大的经济负担。虽然修复骨缺损的传统方法主要是自体移植,但存在一些缺点限制了其应用。骨移植替代物已被用作改善骨愈合的替代策略。然而,要实现理想的愈合效果仍存在一些障碍。可注射水凝胶因其在填充不规则尺寸骨缺损方面的高性能以及封装细胞和生物活性分子并模拟骨天然细胞外基质的能力,已成为骨再生有吸引力的支架材料。我们研究了使用基于壳聚糖的可注射水凝胶支架在体外促进前成骨细胞分化。通过评估细胞均匀性、细胞活力、流变学和力学性能以及前成骨细胞在水凝胶支架中的分化能力来表征水凝胶。载有细胞的水凝胶支架表现出剪切变稀行为以及注射后保持形状保真度的能力。如碱性磷酸酶活性测定和水凝胶支架的组织学分析所示,CNC-CS水凝胶表现出更高的机械强度,并显著上调前成骨细胞的成骨活性和分化。这些结果表明,这种可注射水凝胶适用于细胞存活,可促进前成骨细胞的成骨分化,并在结构上支持新骨生长。